Fonte: The Journal of Urology. Nome do evento: Annual Meeting /AUA. Unidade: FM
Assuntos: OSTEOPOROSE (ETIOLOGIA), NEOPLASIAS PROSTÁTICAS (COMPLICAÇÕES), PREVALÊNCIA
ABNT
CAMARA, Cesar et al. High prevalence of metabolic syndrome in patients under long-term hormonal therapy for prostate cancer, preliminary report. The Journal of Urology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 23 jul. 2024. , 2008APA
Camara, C., Dall'Oglio, M. F., Segre, C. A., Shiraishi, K. S., Srougi, M., Hayek, O., et al. (2008). High prevalence of metabolic syndrome in patients under long-term hormonal therapy for prostate cancer, preliminary report. The Journal of Urology. Baltimore: Faculdade de Medicina, Universidade de São Paulo.NLM
Camara C, Dall'Oglio MF, Segre CA, Shiraishi KS, Srougi M, Hayek O, Oliveira LN, Nesrallah A, Coelho RF, Ebaid G, Murta CB, Crippa A, Alves LR, Serrano CV. High prevalence of metabolic syndrome in patients under long-term hormonal therapy for prostate cancer, preliminary report. The Journal of Urology. 2008 ; 179( 4): 142-143.[citado 2024 jul. 23 ]Vancouver
Camara C, Dall'Oglio MF, Segre CA, Shiraishi KS, Srougi M, Hayek O, Oliveira LN, Nesrallah A, Coelho RF, Ebaid G, Murta CB, Crippa A, Alves LR, Serrano CV. High prevalence of metabolic syndrome in patients under long-term hormonal therapy for prostate cancer, preliminary report. The Journal of Urology. 2008 ; 179( 4): 142-143.[citado 2024 jul. 23 ]